DB

Deutsche Biotech Innovativ AGFRA Deutsche Biotech Stock Report

Last reporting period 30 Jun, 2020

Updated —

Last price

Market cap $B

0.032

Micro

Exchange

XFRA - Deutsche Boerse AG

View Section: Financials

Deutsche Biotech Statements

DB

Deutsche Biotech Income Statement

B

M

EUR (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2020-06-30
%

100

0

0

0

0.01

0

0.05

0

-0.05

0

-0.005

0

0

-0.055

0

0

-0.055

0

-0.058

0.947

2019-12-31
%

100

0

0

0

0

0.04

0

-0.04

0

-0.312

0

0

-0.352

0

0

-0.352

0

-0.372

0.947

2019-06-30
%

100

0

0

0

0.009

0

0.049

0

-0.049

0

-0.003

0

0

-0.052

0

0

-0.052

0

-0.055

0.947

2018-12-31
%

0.044

100

0

0

0

0.069

157.3

0.124

284.6

-0.081

-184.6

-0.001

-2.9

0

-0.082

-187.5

0

-0.082

-187.5

-0.086

0.947

2018-06-30
%

0.077

100

0

0

0

0.116

151.2

0.16

208.9

-0.084

-108.9

0

0

-0.084

-108.9

0

-0.084

-108.9

-0.088

0.947

2017-12-31

0.073

100

0

0

0

0.126

172.9

0.225

309.3

-0.152

-209.3

0

0

-0.152

-209.3

0

-0.152

-209.3

-0.16

0.951

2017-06-30

0.146

100

0

0.146

100

0

0.168

115

0.248

169.8

-0.102

-69.8

0

0

-0.102

-69.8

0

-0.102

-69.8

-0.108

0.944

View Section: Balance Sheet